HomeMNKD • NASDAQ
add
MannKind Corp
$6.84
Makalipas ang Oras ng Trabaho:(0.58%)+0.040
$6.88
Sarado: Nob 22, 7:16:22 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$6.90
Sakop ng araw
$6.82 - $7.01
Sakop ng taon
$3.17 - $7.62
Market cap
1.89B USD
Average na Volume
2.53M
P/E ratio
96.18
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 70.08M | 36.73% |
Gastos sa pagpapatakbo | 36.84M | 8.46% |
Net na kita | 11.55M | 571.12% |
Net profit margin | 16.48 | 390.48% |
Kita sa bawat share | 0.04 | 300.00% |
EBITDA | 17.33M | 326.29% |
Aktuwal na % ng binabayarang buwis | 10.26% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 257.49M | 72.33% |
Kabuuang asset | 464.20M | 44.91% |
Kabuuang sagutin | 674.13M | 17.83% |
Kabuuang equity | -209.93M | — |
Natitirang share | 275.78M | — |
Presyo para makapag-book | -9.08 | — |
Return on assets | 8.38% | — |
Return on capital | 30.69% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 11.55M | 571.12% |
Cash mula sa mga operasyon | 9.33M | 7.70% |
Cash mula sa pag-invest | -41.26M | -257.23% |
Cash mula sa financing | -2.34M | -727.56% |
Net change in cash | -34.27M | -981.66% |
Malayang cash flow | 5.19M | 157.08% |
Tungkol
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Itinatag
Peb 1991
Headquarters
Website
Mga Empleyado
413
